Ver publicación 

Mostrar el registro sencillo de la publicación

Docosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approach

dc.contributor.authorSoto-Alarcon, Sandra
dc.contributor.authorOrtiz, Macarena
dc.contributor.authorOrellana, Paula
dc.contributor.authorEcheverría, Francisca
dc.contributor.authorBustamante, Andrés
dc.contributor.authorEspinosa, Alejandra
dc.contributor.authorIllesca, Paola
dc.contributor.authorGonzalez-Mañán, Daniel
dc.contributor.authorValenzuela, Rodrigo
dc.contributor.authorVidela, Luis A.
dc.date.accessioned2023-01-16T19:18:52Z
dc.date.available2023-01-16T19:18:52Z
dc.date.issued2019
dc.identifier.urihttp://repositorio.ucm.cl/handle/ucm/4366
dc.description.abstractAttenuation of high-fat diet (HFD)-induced liver steatosis is accomplished by different nutritional interventions. Considering that the n-3 PUFA docosahexaenoic acid (DHA) modulates lipid metabolism and the antioxidant hydroxytyrosol (HT) diminishes oxidative stress underlying fatty liver, it is hypothesized that HFD-induced steatosis is suppressed by DHA and HT co-administration. Male C57BL/6J mice were fed a control diet (CD; 10% fat, 20% protein, 70% carbohydrates) or a HFD (60% fat, 20% protein, 20% carbohydrates) for 12 weeks, without and with supplementation of DHA (50 mg/kg/day), HT (5 mg/kg/day) or both. The combined DHA + HT protocol fully prevented liver steatosis and the concomitant pro-inflammatory state induced by HFD, with suppression of lipogenic and oxidative stress signaling, recovery of fatty acid oxidation capacity and enhancement in resolvin availability affording higher inflammation resolution capability. Abrogation of HFD-induced hepatic steatosis by DHA and HT co-administration represents a crucial therapeutic strategy eluding disease progression into stages lacking efficacious handling at present time.es_CL
dc.language.isoenes_CL
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 Chile*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
dc.sourceBioFactors, 45(6), 930-943es_CL
dc.subjectDocosahexaenoic acides_CL
dc.subjectHydroxytyrosoles_CL
dc.subjectLiver steatosises_CL
dc.subjectOxidative stresses_CL
dc.subjectPro-inflammatory statuses_CL
dc.titleDocosahexaenoic acid and hydroxytyrosol co-administration fully prevents liver steatosis and related parameters in mice subjected to high-fat diet: A molecular approaches_CL
dc.typeArticlees_CL
dc.ucm.facultadFacultad de Ciencias de la Saludes_CL
dc.ucm.indexacionScopuses_CL
dc.ucm.indexacionIsies_CL
dc.ucm.uriiubmb.onlinelibrary.wiley.com/doi/10.1002/biof.1556es_CL
dc.ucm.doidoi.org/10.1002/biof.1556es_CL


Ficheros en la publicación

FicherosTamañoFormatoVer

No hay ficheros asociados a esta publicación.

Esta publicación aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo de la publicación

Atribución-NoComercial-SinDerivadas 3.0 Chile
Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile